Enfusion, Inc. (NYSE:ENFN) Shares Sold by Scalar Gauge Management LLC

Scalar Gauge Management LLC trimmed its holdings in Enfusion, Inc. (NYSE:ENFN) by 26.1% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 453,513 shares of the company’s stock after selling 160,000 shares during the period. Enfusion comprises approximately 2.3% of Scalar Gauge Management LLC’s holdings, making the stock its 13th largest holding. Scalar Gauge Management LLC owned about 0.35% of Enfusion worth $4,304,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in ENFN. Renaissance Technologies LLC grew its position in shares of Enfusion by 167.6% in the 2nd quarter. Renaissance Technologies LLC now owns 97,100 shares of the company’s stock worth $827,000 after acquiring an additional 60,811 shares in the last quarter. Squarepoint Ops LLC acquired a new stake in shares of Enfusion during the second quarter worth $683,000. SG Americas Securities LLC acquired a new stake in shares of Enfusion during the third quarter worth $892,000. Versor Investments LP acquired a new position in shares of Enfusion in the 3rd quarter valued at about $501,000. Finally, Impax Asset Management Group plc boosted its holdings in shares of Enfusion by 25.4% in the 3rd quarter. Impax Asset Management Group plc now owns 676,948 shares of the company’s stock valued at $6,424,000 after buying an additional 136,948 shares during the period. 81.05% of the stock is currently owned by hedge funds and other institutional investors.

Enfusion Stock Down 0.8 %

ENFN opened at $9.94 on Friday. The company’s 50-day moving average price is $9.32 and its 200 day moving average price is $8.89. Enfusion, Inc. has a fifty-two week low of $7.52 and a fifty-two week high of $10.45. The firm has a market cap of $1.28 billion, a price-to-earnings ratio of 248.56, a price-to-earnings-growth ratio of 3.75 and a beta of 0.93.

Enfusion Company Profile

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.